Companies / LLY vs ABBV
LLY vs ABBV: Eli Lilly and AbbVie
Eli Lilly (LLY) reported $65.2B in revenue against a 31.7% net margin, while AbbVie (ABBV) reported $61.2B at a 6.9% net margin, most recently.
| Metric | LLY | ABBV |
|---|---|---|
| Revenue | $65.2B | $61.2B |
| Net Income | $20.6B | $4.2B |
| Gross Margin | 83.0% | 70.2% |
| Operating Margin | — | 24.6% |
| EPS (Diluted) | $22.95 | $2.36 |
| Free Cash Flow | — | $17.8B |
| Total Debt | $42.5B | $67.0B |
| P/E Ratio | 46.9× | 96.8× |
| P/B Ratio | n/m | n/m |
| Stock Price | $1375.19 | $288.14 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| ABBV Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $56.2B | $58.1B | $54.3B | $56.3B | $61.2B |